vs
APOGEE ENTERPRISES, INC.（APOG）与IONIS PHARMACEUTICALS INC（IONS）财务数据对比。点击上方公司名可切换其他公司
APOGEE ENTERPRISES, INC.的季度营收约是IONIS PHARMACEUTICALS INC的1.7倍（$351.4M vs $203.3M），APOGEE ENTERPRISES, INC.净利率更高（4.7% vs -112.8%，领先117.5%），APOGEE ENTERPRISES, INC.同比增速更快（1.6% vs -10.3%），过去两年IONIS PHARMACEUTICALS INC的营收复合增速更高（30.4% vs 2.9%）
Apogee Enterprises是一家美国音频设备制造商，主营音频接口、模数与数模转换器、USB及iOS麦克风，同时还开发音频制作相关软件，产品广泛服务于专业录音、音乐创作等音频领域，在全球音频行业拥有较高的认可度。
IONIS制药是1989年成立的生物科技企业，总部位于美国加利福尼亚州卡尔斯巴德，专注于反义疗法、RNA干扰及CRISPR疗法的研发，2015年12月前曾以Isis制药的名称运营。
APOG vs IONS — 直观对比
营收规模更大
APOG
是对方的1.7倍
$203.3M
营收增速更快
APOG
高出11.9%
-10.3%
净利率更高
APOG
高出117.5%
-112.8%
两年增速更快
IONS
近两年复合增速
2.9%
损益表 — Q4 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $351.4M | $203.3M |
| 净利润 | $16.6M | $-229.4M |
| 毛利率 | 22.4% | 96.1% |
| 营业利润率 | 7.3% | -105.5% |
| 净利率 | 4.7% | -112.8% |
| 营收同比 | 1.6% | -10.3% |
| 净利润同比 | 568.8% | -119.8% |
| 每股收益（稀释后） | $0.78 | $-1.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APOGIONS
| Q1 26 | $351.4M | — | ||
| Q4 25 | $348.6M | $203.3M | ||
| Q3 25 | $358.2M | $156.7M | ||
| Q2 25 | $346.6M | $452.0M | ||
| Q1 25 | $345.7M | $131.6M | ||
| Q4 24 | $341.3M | $226.6M | ||
| Q3 24 | $342.4M | $133.8M | ||
| Q2 24 | $331.5M | $225.3M |
净利润APOGIONS
| Q1 26 | $16.6M | — | ||
| Q4 25 | $16.5M | $-229.4M | ||
| Q3 25 | $23.6M | $-128.6M | ||
| Q2 25 | $-2.7M | $123.6M | ||
| Q1 25 | $2.5M | $-146.9M | ||
| Q4 24 | $21.0M | $-104.3M | ||
| Q3 24 | $30.6M | $-140.5M | ||
| Q2 24 | $31.0M | $-66.3M |
毛利率APOGIONS
| Q1 26 | 22.4% | — | ||
| Q4 25 | 23.8% | 96.1% | ||
| Q3 25 | 23.1% | 98.5% | ||
| Q2 25 | 21.7% | 99.1% | ||
| Q1 25 | 21.6% | 98.9% | ||
| Q4 24 | 26.1% | 98.3% | ||
| Q3 24 | 28.4% | 99.2% | ||
| Q2 24 | 29.8% | 98.2% |
营业利润率APOGIONS
| Q1 26 | 7.3% | — | ||
| Q4 25 | 7.1% | -105.5% | ||
| Q3 25 | 7.5% | -102.2% | ||
| Q2 25 | 2.0% | 30.9% | ||
| Q1 25 | 1.8% | -111.6% | ||
| Q4 24 | 8.4% | -48.9% | ||
| Q3 24 | 12.3% | -111.1% | ||
| Q2 24 | 12.5% | -29.3% |
净利率APOGIONS
| Q1 26 | 4.7% | — | ||
| Q4 25 | 4.7% | -112.8% | ||
| Q3 25 | 6.6% | -82.1% | ||
| Q2 25 | -0.8% | 27.3% | ||
| Q1 25 | 0.7% | -111.6% | ||
| Q4 24 | 6.1% | -46.1% | ||
| Q3 24 | 8.9% | -105.0% | ||
| Q2 24 | 9.4% | -29.4% |
每股收益（稀释后）APOGIONS
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.77 | $-1.35 | ||
| Q3 25 | $1.10 | $-0.80 | ||
| Q2 25 | $-0.13 | $0.70 | ||
| Q1 25 | $0.12 | $-0.93 | ||
| Q4 24 | $0.96 | $-0.66 | ||
| Q3 24 | $1.40 | $-0.95 | ||
| Q2 24 | $1.41 | $-0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $39.5M | $2.7B |
| 总债务越低越好 | $232.3M | $1.8B |
| 股东权益账面价值 | $511.8M | $489.1M |
| 总资产 | $1.1B | $3.5B |
| 负债/权益比越低杠杆越低 | 0.45× | 3.71× |
8季度趋势，按日历期对齐
现金及短期投资APOGIONS
| Q1 26 | $39.5M | — | ||
| Q4 25 | $41.3M | $2.7B | ||
| Q3 25 | $39.5M | $2.2B | ||
| Q2 25 | $32.8M | $2.3B | ||
| Q1 25 | $41.4M | $2.1B | ||
| Q4 24 | $43.9M | $2.3B | ||
| Q3 24 | $51.0M | $2.5B | ||
| Q2 24 | $30.4M | $2.1B |
总债务APOGIONS
| Q1 26 | $232.3M | — | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $285.0M | — | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益APOGIONS
| Q1 26 | $511.8M | — | ||
| Q4 25 | $512.3M | $489.1M | ||
| Q3 25 | $500.2M | $618.0M | ||
| Q2 25 | $481.8M | $631.7M | ||
| Q1 25 | $487.9M | $475.7M | ||
| Q4 24 | $522.1M | $588.4M | ||
| Q3 24 | $506.4M | $662.5M | ||
| Q2 24 | $480.0M | $263.7M |
总资产APOGIONS
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $3.5B | ||
| Q3 25 | $1.2B | $3.0B | ||
| Q2 25 | $1.2B | $3.0B | ||
| Q1 25 | $1.2B | $2.8B | ||
| Q4 24 | $1.2B | $3.0B | ||
| Q3 24 | $917.1M | $3.1B | ||
| Q2 24 | $889.0M | $2.7B |
负债/权益比APOGIONS
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | 3.71× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | — | 2.13× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $122.5M | $-137.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-159.0M |
| 自由现金流率自由现金流/营收 | — | -78.2% |
| 资本支出强度资本支出/营收 | 7.8% | 10.5% |
| 现金转化率经营现金流/净利润 | 7.37× | — |
| 过去12个月自由现金流最近4个季度 | — | $-320.0M |
8季度趋势，按日历期对齐
经营现金流APOGIONS
| Q1 26 | $122.5M | — | ||
| Q4 25 | $29.3M | $-137.7M | ||
| Q3 25 | $57.1M | $-131.4M | ||
| Q2 25 | $-19.8M | $151.3M | ||
| Q1 25 | $30.0M | $-150.8M | ||
| Q4 24 | $31.0M | $-116.1M | ||
| Q3 24 | $58.7M | $-115.0M | ||
| Q2 24 | $5.5M | $-119.9M |
自由现金流APOGIONS
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | $-159.0M | ||
| Q3 25 | $52.4M | $-136.7M | ||
| Q2 25 | $-26.9M | $139.0M | ||
| Q1 25 | $19.1M | $-163.4M | ||
| Q4 24 | $22.0M | $-141.6M | ||
| Q3 24 | $50.2M | $-124.0M | ||
| Q2 24 | $-1.8M | $-126.1M |
自由现金流率APOGIONS
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | -78.2% | ||
| Q3 25 | 14.6% | -87.2% | ||
| Q2 25 | -7.8% | 30.8% | ||
| Q1 25 | 5.5% | -124.1% | ||
| Q4 24 | 6.4% | -62.5% | ||
| Q3 24 | 14.7% | -92.7% | ||
| Q2 24 | -0.5% | -56.0% |
资本支出强度APOGIONS
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.9% | 10.5% | ||
| Q3 25 | 1.3% | 3.4% | ||
| Q2 25 | 2.1% | 2.7% | ||
| Q1 25 | 3.2% | 9.6% | ||
| Q4 24 | 2.6% | 11.3% | ||
| Q3 24 | 2.5% | 6.8% | ||
| Q2 24 | 2.2% | 2.8% |
现金转化率APOGIONS
| Q1 26 | 7.37× | — | ||
| Q4 25 | 1.77× | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | — | 1.22× | ||
| Q1 25 | 12.08× | — | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | 1.92× | — | ||
| Q2 24 | 0.18× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
IONS
| Products | $58.0M | 29% |
| Spinraza Royalties | $54.0M | 27% |
| Collaborative Agreement Revenue | $52.4M | 26% |
| Wainus Royalties | $16.0M | 8% |
| Wainua Joint Development Revenue | $9.6M | 5% |
| Other Commercial | $7.6M | 4% |
| Other Royalties | $5.7M | 3% |
